New York Methodist Hospital - SC/Thalassemia Program — Brooklyn, New York

New York Methodist Hospital - SC/Thalassemia Program is a clinical research site located in Brooklyn, New York, United States 11215.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

New York Methodist Hospital - SC/Thalassemia Program has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Anemia, Sickle ß0-Thalassemia.

Sponsors: Emmaus Medical, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Methodist Hospital - SC/Thalassemia Program?

New York Methodist Hospital - SC/Thalassemia Program has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Methodist Hospital - SC/Thalassemia Program conducted?

New York Methodist Hospital - SC/Thalassemia Program has 1 clinical trials on record. Their work covers Sickle Cell Anemia, Sickle ß0-Thalassemia.

Is New York Methodist Hospital - SC/Thalassemia Program accredited by Crixeo Health?

New York Methodist Hospital - SC/Thalassemia Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Methodist Hospital - SC/Thalassemia Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.